Jens Rüter
About
In The Last Decade
Jens Rüter
19 papers receiving 728 citations
Peers
Comparison fields: 5 of 66
- Immunology 403
- Oncology 384
- Endocrine and Autonomic Systems 113
- Physiology 98
- Nutrition and Dietetics 84
Countries citing papers authored by Jens Rüter
This map shows the geographic impact of Jens Rüter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Rüter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Rüter more than expected).
Fields of papers citing papers by Jens Rüter
This network shows the impact of papers produced by Jens Rüter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Rüter. The network helps show where Jens Rüter may publish in the future.
Co-authorship network of co-authors of Jens Rüter
This figure shows the co-authorship network connecting the top 25 collaborators of Jens Rüter. A scholar is included among the top collaborators of Jens Rüter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Rüter. Jens Rüter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 0 | |
| 3 | 234 | |
| 4 | 117 | |
| 5 | 55 | |
| 6 | 50 | |
| 7 | 3 | |
| 8 | 20 | |
| 9 | Phase II trial of Ontak to deplete regulatory T cells in treatment-refractory stage III/IV ovarian cancer | 1 |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 31 | |
| 15 | 79 | |
| 16 | 69 | |
| 17 | 18 | |
| 18 | 5 | |
| 19 | 10 | |
| 20 | [Stimulation of DPN metabolic processes in ascites tumors by low dosage roentgen irradiation and trenimon]. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.